BIOMEA Fusion Strengthens its Executive Team with Appointment of Franco Valle as Chief Financial Officer
Mr. Valle will also assume the role of Principal Financial Officer and Principal Accounting Officer upon joining.
- Mr. Valle will also assume the role of Principal Financial Officer and Principal Accounting Officer upon joining.
- Prior to Eidos, Mr. Valle served as the Principal Accounting Officer and Controller at Iovance Biotherapeutics (Nasdaq: IOVA) from 2016 until 2018.
- I am really excited to welcome Franco to our leadership team, said Tom Butler, Biomeas CEO and Chairman of the Board.
- On behalf of the entire Biomea team, I welcome Franco and look forward to his contributions.